Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Non-Current Debt: 2014-2025

Historic Non-Current Debt for Zevra Therapeutics (ZVRA) over the last 6 years, with Sep 2025 value amounting to $61.3 million.

  • Zevra Therapeutics' Non-Current Debt rose 4.08% to $61.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.3 million, marking a year-over-year increase of 4.08%. This contributed to the annual value of $59.5 million for FY2024, which is 1074.58% up from last year.
  • Latest data reveals that Zevra Therapeutics reported Non-Current Debt of $61.3 million as of Q3 2025, which was up 1.02% from $60.7 million recorded in Q2 2025.
  • Zevra Therapeutics' Non-Current Debt's 5-year high stood at $61.3 million during Q3 2025, with a 5-year trough of $98,000 in Q1 2021.
  • Its 3-year average for Non-Current Debt is $42.4 million, with a median of $58.3 million in 2024.
  • Per our database at Business Quant, Zevra Therapeutics' Non-Current Debt crashed by 60.42% in 2023 and then skyrocketed by 1,074.58% in 2024.
  • Quarterly analysis of 5 years shows Zevra Therapeutics' Non-Current Debt stood at $98,000 in 2021, then reached $12.8 million in 2022, then crashed by 60.42% to $5.1 million in 2023, then spiked by 1,074.58% to $59.5 million in 2024, then climbed by 4.08% to $61.3 million in 2025.
  • Its Non-Current Debt was $61.3 million in Q3 2025, compared to $60.7 million in Q2 2025 and $60.1 million in Q1 2025.